Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joseph P. Reoux"'
Autor:
Donald A. Calsyn, Daniel R. Kivlahan, Tania M. Davis Correale, Kristen R. Bush, John W. Davison, Joseph P. Reoux, Marie L. Sweeney, Kevin L. Sloan
Publikováno v:
Journal of Addictive Diseases. 25:27-35
Many patients with chronic opioid dependence are referred to drug-free outpatient treatment following inpatient detoxification even though successful outpatient treatment engagement and abstinence from opioids occur only in a minority of cases. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0c187149cfced9608b71476eeaa29e
https://doi.org/10.1300/j069v25n04_03
https://doi.org/10.1300/j069v25n04_03
Autor:
Michael R. Oreskovich, Joseph P. Reoux
Publikováno v:
American Journal on Addictions. 15:85-93
Scores from two versions of the Clinical Institute Withdrawal Assessment for Alcohol, the CIWA-Ar and CIWA-AD, were compared in 135 alcohol detoxification episodes. The paired mean score for withdrawal severity was statistically higher with the CIWA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eddb0707b202729c04c51d7325d1dfd
https://doi.org/10.1080/10550490500419136
https://doi.org/10.1080/10550490500419136
Autor:
Patricia C. Knox, Andrew J. Saxon, Joseph P. Reoux, Mei Ling K. Ellis, Carol A. Malte, Michael R. Oreskovich
Publikováno v:
Drug and Alcohol Dependence. 77:71-79
The optimum dose of buprenorphine for acute inpatient heroin detoxification has not been determined. This randomized, double-blind, double-dummy, pilot study compares two buprenorphine sublingual tablet dosing schedules to oral clonidine. Heroin user
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a60a8f646b4652fd7a6c37ddc4664e
https://doi.org/10.1016/j.drugalcdep.2004.07.008
https://doi.org/10.1016/j.drugalcdep.2004.07.008
Publikováno v:
Journal of Addictive Diseases. 21:81-91
We evaluated whether the Alcohol Use Disorders Identification Test (AUDIT) predicted clinically meaningful alcohol withdrawal syndrome (AWS) in 118 alcohol dependent patients without a history of seizures. Patients were monitored by serial administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764cf9714341a34677f95cf08c7a67d0
https://doi.org/10.1300/j069v21n04_08
https://doi.org/10.1300/j069v21n04_08
Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Publikováno v:
Alcoholism: Clinical and Experimental Research. 25:1324-1329
Background: Divalproex sodium, an anticonvulsant and antikindling agent and γ-aminobutyric acid enhancer, has been proposed as an alternative to benzodiazepines for treating alcohol withdrawal. This study reports on a randomized, double-blind, place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd5da516d7f8d14479fbff546248542b
https://doi.org/10.1111/j.1530-0277.2001.tb02354.x
https://doi.org/10.1111/j.1530-0277.2001.tb02354.x
Autor:
Joseph P. Reoux, Kristin A. Miller
Publikováno v:
American Journal on Addictions. 9:135-144
Charts of patients hospitalized for uncomplicated alcohol withdrawal were examined and detoxification practices compared. Patients detoxified using a Clinical Institute Withdrawal Assessment for Alcohol-revised (CIWA-Ar) based PRN protocol on the add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278dc9de4a752a9082ea586e0873ec0b
https://doi.org/10.1080/10550490050173208
https://doi.org/10.1080/10550490050173208
Publikováno v:
The Journal of Clinical Psychiatry. 59:313-316
Background Concern about the precipitation of severe hepatitis by disulfiram often causes clinicians to avoid using this effective treatment in patients who have elevated baseline transaminase levels, even though no empirical evidence has so far show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9469e9156411c08166ac3cad5a93f111
https://doi.org/10.4088/jcp.v59n0607
https://doi.org/10.4088/jcp.v59n0607
Autor:
Joseph P Reoux
Publikováno v:
Journal of Clinical Psychopharmacology; Feb2006, Vol. 26 Issue 1, p105-107, 3p